Bio-Rad Laboratories Profit Margin

As of the most recent data (September 2026), BIO shows a profit margin of 39.45%. That compares with -28.93% in the prior-year period — up 236.4% year over year. That is above the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIO's profit margin is now 39.45% (was -28.93%) — a 236.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Rad Laboratories is outperforming or lagging.

The Healthcare sector average profit margin is about 17.63%. Bio-Rad Laboratories is at 39.45%, which is higher that average. That is roughly 123.8% above the sector mean. Use the comparison chart on this page to see how BIO stacks up against individual peers as well.

That compares with -28.93% in the prior-year period — up 236.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Bio-Rad Laboratories with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Bio-Rad Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 39.45%) with ownership activity and broader fundamentals.